Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary sclerosing cholangitis

L F Williams, D J Schoetz

    The Surgical Clinics of North America
    |August 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Primary sclerosing cholangitis (PSC) treatment with steroids and azathioprine has not improved outcomes. Biliary drainage remains the primary therapy, with new endoscopic techniques potentially altering surgical approaches.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    What is the optimal management of an intra-operative air leak in a colorectal anastomosis?

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2017
    Same author

    Small optic suspensions for Advanced LIGO input optics and other precision optical experiments.

    The Review of scientific instruments·2016
    Same author

    What are 30-day postoperative outcomes following splenic flexure mobilization during anterior resection?

    Techniques in coloproctology·2013
    Same author

    Management of anal fistulas in Crohn's disease: a surgical perspective.

    Inflammatory bowel diseases·2013
    Same author

    The pouch and indeterminate colitis: time will tell.

    Inflammatory bowel diseases·2013
    Same author

    How often do patients return to the operating room after colorectal resections?

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2011
    Same journal

    Social Determinants of Health, Health Disparities, and Surgical Equity.

    The Surgical clinics of North America·2026
    Same journal

    Beyond the Scalpel's Reach.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions-Society.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions-Hospitals.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions for Providers.

    The Surgical clinics of North America·2026
    Same journal

    Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

    The Surgical clinics of North America·2026
    See all related articles

    Area of Science:

    • Gastroenterology and Hepatology
    • Surgical Management of Biliary Diseases

    Background:

    • Primary sclerosing cholangitis (PSC) is a chronic liver disease with limited treatment options.
    • Current understanding of PSC etiology suggests immunosuppressive therapy, including steroids and azathioprine, but efficacy is limited.

    Observation:

    • Pharmacological interventions have not significantly altered the disease's ultimate outcome.
    • Biliary drainage is the most accepted therapeutic approach when feasible.
    • Advances in ERCP and transhepatic biliary drainage offer new diagnostic and therapeutic possibilities.

    Findings:

    • Surgical management requires a high index of suspicion during laparotomy to prevent biliary tree damage before diagnosis.
    • Simple biliary drainage can offer symptomatic relief for some patients.

    Related Experiment Videos

  • Despite current treatments, many patients progress to biliary cirrhosis or sepsis.
  • Implications:

    • New endoscopic techniques may shift the paradigm from traditional surgical interventions for PSC.
    • Early and accurate diagnosis is crucial for effective surgical management and preventing irreversible biliary damage.
    • Further research is needed to improve long-term outcomes for patients with primary sclerosing cholangitis.